Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pihlström

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Pediatrics|January 10, 2024
COVID-19 Vaccine Effectiveness Among AdolescentsEero Poukka, Niklas Worm Andersson, Emilia Myrup Thiesson, et al.
JBMR Plus|October 27, 2025
Utilizing CRISPR-Cas13d-knockdown in zebrafish to study a rare monogenic bone fragility syndromeKirsi Määttä, Yu-Chia Chen, Sandra Pihlström, et al.
The Journal of Infection|September 1, 2024
Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort studyMie Agermose Gram, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
Upsala Journal of Medical Sciences|November 5, 2025
Overview of approved COVID-19 vaccines in the EU, recommendations for use in Sweden and vaccine uptake over time: Report from the Swedish Medical Products Agency and the Public Health Agency of SwedenBjörn Zethelius, Johanna Rubin, Nicklas Pihlström, et al.
BMJ (Clinical Research Ed.)|July 25, 2023
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort studyNiklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
Upsala Journal of Medical Sciences|May 24, 2023
Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccinesRolf Gedeborg, Lennart Holm, Nils Feltelius, et al.
Rheumatology (Oxford, England)|November 22, 2025
SARS-CoV-2 vaccination and myositis in Norway and SwedenRickard Ljung, Nicklas Pihlström, Jesper Dahl, et al.
BMJ Medicine|March 20, 2023
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort studyAnders Husby, Hanne Løvdal Gulseth, Petteri Hovi, et al.
JBMR Plus|September 22, 2025
Transcriptomic and lipidomic profiling provide novel insight into the pathogenesis of monogenic <i>SGMS2</i>-related osteoporosisSandra Pihlström, Ali Oghabian, Kirsi Määttä, et al.
European Heart Journal|February 16, 2024
Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort studyAnders Hviid, Tuomo A Nieminen, Nicklas Pihlström, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Pediatrics|January 10, 2024
COVID-19 Vaccine Effectiveness Among AdolescentsEero Poukka, Niklas Worm Andersson, Emilia Myrup Thiesson, et al.
JBMR Plus|October 27, 2025
Utilizing CRISPR-Cas13d-knockdown in zebrafish to study a rare monogenic bone fragility syndromeKirsi Määttä, Yu-Chia Chen, Sandra Pihlström, et al.
The Journal of Infection|September 1, 2024
Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort studyMie Agermose Gram, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
Upsala Journal of Medical Sciences|November 5, 2025
Overview of approved COVID-19 vaccines in the EU, recommendations for use in Sweden and vaccine uptake over time: Report from the Swedish Medical Products Agency and the Public Health Agency of SwedenBjörn Zethelius, Johanna Rubin, Nicklas Pihlström, et al.
BMJ (Clinical Research Ed.)|July 25, 2023
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort studyNiklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
Upsala Journal of Medical Sciences|May 24, 2023
Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccinesRolf Gedeborg, Lennart Holm, Nils Feltelius, et al.
Rheumatology (Oxford, England)|November 22, 2025
SARS-CoV-2 vaccination and myositis in Norway and SwedenRickard Ljung, Nicklas Pihlström, Jesper Dahl, et al.
BMJ Medicine|March 20, 2023
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort studyAnders Husby, Hanne Løvdal Gulseth, Petteri Hovi, et al.
JBMR Plus|September 22, 2025
Transcriptomic and lipidomic profiling provide novel insight into the pathogenesis of monogenic <i>SGMS2</i>-related osteoporosisSandra Pihlström, Ali Oghabian, Kirsi Määttä, et al.
European Heart Journal|February 16, 2024
Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort studyAnders Hviid, Tuomo A Nieminen, Nicklas Pihlström, et al.
Pageof 4